维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="STOTER G"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Casein kinase 1 delta ( CK1 δ) interacts with the SNARE associated protein SNAPIN 显示文摘	Wolff S Stoter M Giamas G	2006	FEBS Lett2006，580，27：	1
2	Molecular mechanisms of multidrug resistance in cancer chemotherapy显示文摘	Nooter K Stoter G	1996	Pathol Res Pract1996，192，7：	1
3	Doeetaxel : single agent activity, development of combination treatment and reducing side-effects 显示文摘	Pronk LC Stoter G Verweij J	1995	Cancer Treat Rev1995，21，5：	1
4	Stenting in malignant ve na caval obstruction显示文摘	Oudkerk M Heystraten FMJ Stoter G	1993	Cancer1993，71，1：	1
5	Microtubules de- polymerization caused by the CK1 inhibitor IC261 May be not mediated by CK1 blockage显示文摘	Stoter M Krtiger M Banting G	2014	PLoS One2014，9，10：	1
6	Lack of c - kit exon 11 activating mutations in c -kit/CDll7 -positive SCLC tumour specimens 显示文摘	Burger H Den Bakker MA Stoter G	2003	Eur J Cancer2003，39，6：	1
7	Stenting in malignant vena caval obstruction显示文摘	Oudkerk M Heystraten FMJ Stoter G	1993	Cancer1993，71，：	1
8	Molecular mechanisms of multidrug resistance in cancer chemotherapy 显示文摘	Nooter K Stoter G	1996	Pathol Res Pract1996，192，7：	1
9	Docetaxel: single agentactivity, development of combination treatment and reducing side-effects显示文摘	Pronk LC Stoter G Verweij J	1995	Cancer Treat Rev1995，21，5：	1
10	Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody显示文摘	Canevari S Stoter G Arienti F	1995	J Natl Cancer Inst1995，87，：	1
11	Molccular mechanisms of muhidrug resistance in cancer chemotherapy显示文摘	Nooter K Stoter G	1996	Pathol Res Pract1996，192，：	1
12	Moleculer mechanisms of multidrug resistance in cancer chemotherapy显示文摘	Nooter K Stoter G	1996	Pathol Res Pract1996，192，7：	1
13	Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumor specimens显示文摘	Burger H den Bakker MA Stoter G	2003	Eur J Cancer2003，39，：	1
14	The correlation of CA15-3 and TPS with tumor course in patients with metastatic breast cancer显示文摘	Stoter G Van Putten W L J	1997	J Cancer Res Clin Oncol1997，123，2：	1
15	Molecular mechanisms of muhidrug re- sistance in cancer chemotherapy显示文摘	Nooter K Stoter G	1996	Pathol Res Pract1996，192，：	1
16	Constitutive expression of the H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line显示文摘	Nooter K Burger H Stoter G	1995	Br J Cancer1995，71，：	1
17	Docetaxel: single agent activity, development of combination treatment and reducing side-effects显示文摘	Pronk LC Stoter G Verweij J	1995	Cancer Treatment Review1995，21，5：	1
18	Molecular mechanisms of muhidrug resistance in cancer chemotherapy显示文摘	Nooter K Stoter G	1996	Pathol Res Pract1996，192，7：	1
19	Docetaxel (Tax- otere): an active agent in metastatic urothelial cancer; re- sults of a phase II study in non-chemotherapy-pretreated patients显示文摘	De Wit R Kruit WH Stoter G	1998	Br J Cancer1998，78，：	1
20	查看详情显示文摘	Wit R Pawinsky A Stoter G		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示